Regulatory Considerations For Scale Up

Source: Cytiva

In the opening segment of Cell & Gene Live, Regulating The CGT Workflow To Improve Patient Safety, our expert panelists, Nimi Chhina, Ph.D., J.D. Executive Director, Head of Global R&D and Regulatory Policy Global Regulatory Affairs, Worldwide Research & Development at BioMarin Pharmaceutical Inc. and Robert G. Pietrusko, Pharm.D., Chief Regulatory & Quality Officer at Vor Biopharma discuss scale up to a commercial product.

access the Video!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Cell & Gene